Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ING Develops AIPowered Trading System in Hours Capturing Wall Streets Attention Italys Top Court Rules No Legal Right to Free Tap Water in Hotels Setting Precedent for Hospitality Industry Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race The Escalating 8 Billion Long COVID Crisis Rising Costs Amidst Federal Retreat US SelfDefense Strikes in Iran Raise Geopolitical Uncertainty Amid Peace Deal Efforts KRMD Q1 2026 Earnings NarrowerThanExpected Loss Amid Flat Revenue Visibility XPO Q1 2026 Earnings EPS Beats Estimates by 14 but Stock Falls on Revenue Concerns PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix AREN Q1 2026 Earnings Significant EPS Miss Despite Share Price Uptick RLGT Q1 2026 Earnings EPS Surpasses Estimates with 659 Beat Alibaba BABA Slides 194 Amid Persistent Headwinds Key Support Levels in Focus Four Seasons Education FEDU Falls Sharply as Stock Tests Key Support at 960 Intelligent Living Application Group ILAG Faces Selling Pressure as Shares Slide 53 Smith Douglas Homes Corp SDHC Gains Ground Approaching Key Resistance Nifty Futures and Bank Nifty Futures Show Firm Resistance Amid Fresh Long Additions Inflation Projected to Reach 6 in Q2 Top Forecasters Warn Bungie Ends Destiny 2 Active Support LiveService Strategy Shift May Affect Sonys Gaming Revenue Nifty 50s LongTerm Historical Performance Sends Reassuring Signal to FPIs Dont Write Me Off Just Yet Oaktree Acquisition Corp III Life Sciences Units OACCU Slip 25 Support Levels in Focus Piper Sandler PIPR Faces Headwinds Stock Slips 22 Amid Market Pressure SailPoint Inc SAIL Surges Over 4 as Shares Approach Resistance Level Centurion Acquisition Corp ALF SPAC Holds Steady Near 1088 Amid Minimal Movement Mountain Lake Acquisition Corp II Units MLAAU Hold Steady at 104 as SPAC Market Waits CanFite Biopharma CANF Slides 262 Toward 318 Support as Selling Pressure Persists